Marketing-authorisation holder · Brazil
Biopas Brasil Produtos Farmaceuticos Ltda
14 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATACAND | Candesartan cilexetil | Brazil | Authorised | 2025 |
| ATACAND HCT | Candesartan cilexetil, Hydrochlorothiazide | Brazil | Authorised | 2025 |
| GEMZAR | Gencitabina | Brazil | Authorised | 2025 |
| LANEXAT | Flumazenil | Brazil | Authorised | 2022 |
| LIVMARLI | Cloreto maralixibate | Brazil | Authorised | 2025 |
| LOSEC | Omeprazole | Brazil | Authorised | 2022 |
| Mevatyl | Tetraidrocanabinol, Cannabidiol | Brazil | Authorised | 2023 |
| ROHYPNOL | Flunitrazepam | Brazil | Authorised | 2026 |
| TARCEVA | Erlotinib | Brazil | Authorised | 2025 |
| TAXOL | Paclitaxel | Brazil | Authorised | 2023 |
| VALCYTE | Valganciclovir | Brazil | Authorised | 2022 |
| VESANOID | Tretinoin | Brazil | Authorised | 2025 |
| XELODA | Capecitabine | Brazil | Authorised | 2022 |
| ZYPREXA | Olanzapine | Brazil | Authorised | 2025 |